"Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
Descriptor ID |
D000368
|
MeSH Number(s) |
M01.060.116.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged".
Below are MeSH descriptors whose meaning is more specific than "Aged".
This graph shows the total number of publications written about "Aged" by people in this website by year, and whether "Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 132 | 133 |
1996 | 0 | 133 | 133 |
1997 | 2 | 153 | 155 |
1998 | 2 | 146 | 148 |
1999 | 0 | 176 | 176 |
2000 | 1 | 208 | 209 |
2001 | 1 | 212 | 213 |
2002 | 3 | 260 | 263 |
2003 | 1 | 314 | 315 |
2004 | 1 | 338 | 339 |
2005 | 0 | 367 | 367 |
2006 | 0 | 396 | 396 |
2007 | 1 | 358 | 359 |
2008 | 2 | 417 | 419 |
2009 | 1 | 446 | 447 |
2010 | 0 | 470 | 470 |
2011 | 0 | 560 | 560 |
2012 | 0 | 589 | 589 |
2013 | 0 | 679 | 679 |
2014 | 0 | 645 | 645 |
2015 | 0 | 693 | 693 |
2016 | 0 | 744 | 744 |
2017 | 0 | 800 | 800 |
2018 | 0 | 804 | 804 |
2019 | 0 | 754 | 754 |
2020 | 0 | 707 | 707 |
2021 | 0 | 556 | 556 |
2022 | 0 | 255 | 255 |
2023 | 0 | 223 | 223 |
2024 | 0 | 611 | 611 |
2025 | 0 | 14 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged" by people in Profiles.
-
Cardiac MRI Evaluation of Determinants and Prognostic Implications of Right Ventricular Dysfunction in Aortic Regurgitation. Radiol Cardiothorac Imaging. 2025 Feb; 7(1):e230389.
-
Impact of Perioperative Anticoagulation and Antiplatelet Therapy on Hearing Preservation Outcomes. Otol Neurotol. 2025 Feb 01; 46(2):128-132.
-
The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):356-363.
-
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clin Cancer Res. 2025 Jan 17; 31(2):258-265.
-
Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated. Acta Neuropathol Commun. 2025 Jan 16; 13(1):9.
-
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma. Blood. 2025 Jan 16; 145(3):290-299.
-
Differential diagnosis in immune checkpoint inhibitors neurotoxicity. J Neurol. 2025 Jan 15; 272(2):116.
-
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial. Nat Commun. 2025 Jan 10; 16(1):578.
-
Examining Lung Cancer Screening Uptake in the United States: Recent Research and Limitations of Public-Use Data. Cancer Epidemiol Biomarkers Prev. 2025 Jan 09; 34(1):9-11.
-
A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors. J Transl Med. 2025 Jan 09; 23(1):37.